247 related articles for article (PubMed ID: 15917090)
21. Mutation of katG in a clinical isolate of Mycobacterium tuberculosis: effects on catalase-peroxidase for isoniazid activation.
Purkan ; Ihsanawati ; Natalia D; Syah YM; Retnoningrum DS; Kusuma HS
Ukr Biochem J; 2016; 88(5):71-81. PubMed ID: 29235814
[TBL] [Abstract][Full Text] [Related]
22. Molecular details of INH-C10 binding to wt KatG and Its S315T mutant.
Teixeira VH; Ventura C; Leitão R; Ràfols C; Bosch E; Martins F; Machuqueiro M
Mol Pharm; 2015 Mar; 12(3):898-909. PubMed ID: 25590860
[TBL] [Abstract][Full Text] [Related]
23. Carbon monoxide adducts of KatG and KatG(S315T) as probes of the heme site and isoniazid binding.
Lukat-Rodgers GS; Wengenack NL; Rusnak F; Rodgers KR
Biochemistry; 2001 Jun; 40(24):7149-57. PubMed ID: 11401561
[TBL] [Abstract][Full Text] [Related]
24. Structural basis for isoniazid resistance in KatG double mutants of Mycobacterium tuberculosis.
Rabha A; Singh A; Grover S; Kumari A; Pandey B; Grover A
Microb Pathog; 2019 Apr; 129():152-160. PubMed ID: 30731190
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA.
Leung ET; Ho PL; Yuen KY; Woo WL; Lam TH; Kao RY; Seto WH; Yam WC
Antimicrob Agents Chemother; 2006 Mar; 50(3):1075-8. PubMed ID: 16495272
[TBL] [Abstract][Full Text] [Related]
26. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.
Zhang Y; Heym B; Allen B; Young D; Cole S
Nature; 1992 Aug; 358(6387):591-3. PubMed ID: 1501713
[TBL] [Abstract][Full Text] [Related]
27. [KatG Ser3 15Thr mutation as the main reason of isoniazid resistance in Mycobacterium tuberculosis isolated in the Novosibirsk and Kemerovo Regions].
Voronina EN; Vikhrova MA; Khrapov EA; Kinsht VN; Norkina OV; Gorbunova EV; Shabaldin AV; Glushkov AN; Krasnov VA; Filipenko ML
Mol Gen Mikrobiol Virusol; 2004; (3):8-11. PubMed ID: 15354935
[TBL] [Abstract][Full Text] [Related]
28. Significance of catalase-peroxidase (KatG) mutations in mediating isoniazid resistance in clinical strains of Mycobacterium tuberculosis.
Unissa AN; Doss C GP; Kumar T; Sukumar S; Lakshmi AR; Hanna LE
J Glob Antimicrob Resist; 2018 Dec; 15():111-120. PubMed ID: 29990547
[TBL] [Abstract][Full Text] [Related]
29. Two [Fe(IV)=O Trp*] intermediates in M. tuberculosis catalase-peroxidase discriminated by multifrequency (9-285 GHz) EPR spectroscopy: reactivity toward isoniazid.
Singh R; Switala J; Loewen PC; Ivancich A
J Am Chem Soc; 2007 Dec; 129(51):15954-63. PubMed ID: 18052167
[TBL] [Abstract][Full Text] [Related]
30. Redox potential measurements of the Mycobacterium tuberculosis heme protein KatG and the isoniazid-resistant enzyme KatG(S315T): insights into isoniazid activation.
Wengenack NL; Lopes H; Kennedy MJ; Tavares P; Pereira AS; Moura I; Moura JJ; Rusnak F
Biochemistry; 2000 Sep; 39(37):11508-13. PubMed ID: 10985797
[TBL] [Abstract][Full Text] [Related]
31. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
Evans J; Stead MC; Nicol MP; Segal H
J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875
[TBL] [Abstract][Full Text] [Related]
32. Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities.
Cade CE; Dlouhy AC; Medzihradszky KF; Salas-Castillo SP; Ghiladi RA
Protein Sci; 2010 Mar; 19(3):458-74. PubMed ID: 20054829
[TBL] [Abstract][Full Text] [Related]
33. [A simple enzyme test for proving the resistance to isoniazid of Mycobacterium tuberculosis strains].
Homorodean D
Pneumologia; 2005; 54(2):58-61. PubMed ID: 16536002
[TBL] [Abstract][Full Text] [Related]
34. Molecular Analysis of
Purkan P; Ihsanawati I; Natalia D; Syah YM; Retnoningrum DS; Siswanto I
J Med Life; 2018; 11(2):160-167. PubMed ID: 30140323
[TBL] [Abstract][Full Text] [Related]
35. Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid.
Wengenack NL; Uhl JR; St Amand AL; Tomlinson AJ; Benson LM; Naylor S; Kline BC; Cockerill FR; Rusnak F
J Infect Dis; 1997 Sep; 176(3):722-7. PubMed ID: 9291321
[TBL] [Abstract][Full Text] [Related]
36. Insights on the Mechanism of Action of INH-C
Vila-Viçosa D; Victor BL; Ramos J; Machado D; Viveiros M; Switala J; Loewen PC; Leitão R; Martins F; Machuqueiro M
Mol Pharm; 2017 Dec; 14(12):4597-4605. PubMed ID: 29091448
[TBL] [Abstract][Full Text] [Related]
37. Purification and characterization of Mycobacterium tuberculosis KatG, KatG(S315T), and Mycobacterium bovis KatG(R463L).
Wengenack NL; Lane BD; Hill PJ; Uhl JR; Lukat-Rodgers GS; Hall L; Roberts GD; Cockerill FR; Brennan PJ; Rodgers KR; Belisle JT; Rusnak F
Protein Expr Purif; 2004 Aug; 36(2):232-43. PubMed ID: 15249045
[TBL] [Abstract][Full Text] [Related]
38. Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands.
van Doorn HR; de Haas PE; Kremer K; Vandenbroucke-Grauls CM; Borgdorff MW; van Soolingen D
Clin Microbiol Infect; 2006 Aug; 12(8):769-75. PubMed ID: 16842572
[TBL] [Abstract][Full Text] [Related]
39. Impact of isoniazid resistance on virulence of global and south Indian clinical isolates of Mycobacterium tuberculosis.
Ameeruddin NU; Luke Elizabeth H
Tuberculosis (Edinb); 2014 Dec; 94(6):557-63. PubMed ID: 25270728
[TBL] [Abstract][Full Text] [Related]
40. Impact of distal side water and residue 315 on ligand binding to ferric Mycobacterium tuberculosis catalase-peroxidase (KatG).
Ranguelova K; Suarez J; Metlitsky L; Yu S; Brejt SZ; Brejt SZ; Zhao L; Schelvis JP; Magliozzo RS
Biochemistry; 2008 Nov; 47(47):12583-92. PubMed ID: 18956888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
